Siste forsøk

EudraCT Number: 2004-000091-14

Sponsor Protocol Number: FFR102123

Start Date: 2004-09-17

Sponsor Name: GlaxoSmithKline, S.A

Full Title: A Randomised, Double-Blind, Placebo-Controlled, Parallel Group, Multicentre, Long-Term Study to Evaluate the Safety of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal Spray 100mcg ...

Medical condition: Perennial allergic rhinitis

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: ES (Completed) SE (Completed) LV (Completed) LT (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2004-002137-39

Sponsor Protocol Number: V1 25/07/04

Start Date: 2004-09-17

Sponsor Name:

Full Title: A randomised controlled trial of the combined use of paracetamol and ibuprofen to treat febrile children

Medical condition: Fevers in childhood not asscoaited with severe disease in the immunocompenetent or fever in the immunocompromised host.

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Infants and toddlers, Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: GB (GB - no longer in EU/EEA)

Trial results: (No results available)

EudraCT Number: 2004-001347-29

Sponsor Protocol Number:

Start Date: 2004-09-17

Sponsor Name: Odense University Hospital

Full Title: Treatment of patients with locally advanced rectal cancer. TEGAFOX (UFT/leukovorin og Oxaliplatin) before, during and after curatively intended radiotherapy. A Danish phase I/II trial

Medical condition: Locally advanced non-resectable rectal cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.0		10038050		LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DK (Prematurely Ended)

Trial results: View results

EudraCT Number: 2005-003701-91

Sponsor Protocol Number: INT 27/04

Start Date: 2004-09-17

Sponsor Name: ISTITUTO NAZIONALE PER LA CURA TUMORI

Full Title: ONCE WEEKLY DOSING OF DARBEPOETIN ALPHA AS PROPHYLACTIC TREATMENT FOR ANEMIA IN ELDERLY CANCER PATIENTS

Medical condition: ELDERLY PATIENTS WITH GASTROINTESTINAL AND LUNG CANCER

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10029104		SOC

Population Age: Elderly

Gender: Male, Female

Trial protocol: IT (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2004-000850-22

Sponsor Protocol Number: 044(2A)SC04030

Start Date: 2004-09-17

Sponsor Name: ANGELINI

Full Title: Evaluation of tolerability and analgesic activity of paracetamol 1000 mg+caffeine 130 mg in the treatment of tension-type headache. Randomized, double blind, double-dummy, cross-over study vs. napr...

Medical condition: Evaluation of tolerability and analgesic activity in the treatment of tension-type headache

Disease:	Version	SOC Term	Classification Code	Term	Level
			10043269		PT

Population Age: Adults

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: View results

EudraCT Number: 2004-000137-11

Sponsor Protocol Number: EMR62202-013

Start Date: 2004-09-17

Sponsor Name: Merck KGaA

Full Title: Open, randomized, controlled, multicenter phase III study comparing 5-FU/FA plus irinotecan plus cetuximab versus 5-FU/FA plus irinotecan as first-line treatment for epidermal growth factor recepto...

Medical condition: First-line treatment for epidermal growth factor receptor-expressing metastatic colorectal cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
	7.0		10052362		LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: HU (Completed) CZ (Completed) SK (Completed) SE (Completed) FI (Completed) IT (Completed) LT (Completed) EE (Completed) GB (Completed) ES (Completed)

Trial results: View results

EudraCT Number: 2004-001075-20

Sponsor Protocol Number: FG-506-17-04

Start Date: 2004-09-16

Sponsor Name: Fujisawa GmbH

Full Title: A MULTICENTER, RANDOMIZED, DOUBLE BLIND, DOUBLE-DUMMY PLACEBO- CONTROLLED PARALLEL-GROUP MULTIPLE DOSE STUDY OF THE EFFICACY AND SAFETY OF TACROLIMUS INHALATION AEROSOL IN PATIENTS WITH MODERATE P...

Medical condition: Moderate persistent asthma

Disease:	Version	SOC Term	Classification Code	Term	Level
	7.0		10003555		LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: LT (Completed)

Trial results: View results

EudraCT Number: 2004-000406-51

Sponsor Protocol Number: EMD20001

Start Date: 2004-09-16

Sponsor Name: GlaxoSmithKline

Full Title: A Prospective, Randomized, Double-blind, Placebo Controlled, Dose Ranging, Multi-Center Study of the Safety and Efficacy of Three Days Continuous Intravenous Infusion of GR270773 in the Treatment o...

Medical condition: Suspected or Confirmed Gram-negative Severe Sepsis in Adults

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FI (Completed) ES (Completed) CZ (Completed) LV (Completed) AT (Completed) HU (Completed) DK (Completed)

Trial results: View results

EudraCT Number: 2004-000632-82

Sponsor Protocol Number: AC-052-333

Start Date: 2004-09-16

Sponsor Name: Actelion Pharmaceuticals Ltd.

Full Title: Long term bosentan open label extension of the RAPIDS-2 study in Systemic Sclerosis patients with ischemic digital ulcers

Medical condition: SSc is a multi-system disorder of unknown etiology characterized by fibrosis and vascular obliteration in the skin and visceral organs. The pathogenesis of SSc involves immunologic mechanisms vascu...

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2004-000530-37

Sponsor Protocol Number: 24978

Start Date: 2004-09-16

Sponsor Name: Serono International S.A.

Full Title: A multicentre, randomised, double blind, placebo controlled phase III study of subcutaneously administered onercept in the initial treatment and continued treatment after extended therapy in subjec...

Medical condition: Psoriasis is an inflammatory skin disorder that affects between 1 and 2% of the population. It is characterised by an increased proliferation of the epidermis, and presents as well-defined thickene...

Disease:	Version	SOC Term	Classification Code	Term	Level
	7.0		10037153		PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: LT (Completed) LV (Completed) EE (Completed)

Trial results: View results

Siste forsøk

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner